Wednesday, July 8, 2026
🇺🇸 FDA

biotech · Atopic Dermatitis · Moderate to Severe Atopic Dermatitis · KYMR

Kymera Therapeutics

Kymera Therapeutics patent portfolio — 29 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
500 North Beacon Street, 4th Floor, Watertown, MA 02472, US HQ
2016 Founded
289 Employees
Public company Type
KYMR · NYSE Ticker
Company details
Status
Public
HQ
500 North Beacon Street, 4th Floor, Watertown, MA 02472, US
Founded
2016
Employees
289
Programs
12
Drugs
6
Patents
29
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

Kymera Therapeutics patents

29 pharmaceutical patents indexed for Kymera Therapeutics. 0 expire within 24 months.

Kymera Therapeutics has 29 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

29 patents

Patent portfolio

  1. US 12258341

    IRAK degraders and uses thereof

    Expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12187744

    IRAK4 degraders and synthesis thereof

    Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12171768

    IRAK4 degraders and uses thereof

    Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12168057

    IRAK degraders and uses thereof

    Expires Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12150995

    IRAK degraders and uses thereof

    Expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12097261

    CDK2 degraders and uses thereof

    Expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12091411

    IRAK degraders and uses thereof

    Expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12077555

    STAT degraders and uses thereof

    Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12006329

    Protein degraders and uses thereof

    Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11932624

    MDM2 degraders and uses thereof

    Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11932635

    CRBN ligands and uses thereof

    Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11857535

    Methods of treating mutant lymphomas

    Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11807636

    IRAK degraders and uses thereof

    Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11779578

    IRAK degraders and uses thereof

    Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11773103

    IRAK4 degraders and uses thereof

    Expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11746120

    Stat degraders and uses thereof

    Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11723980

    IRAK degraders and uses thereof

    Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11707457

    IRAK degraders and uses thereof

    Expires Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11685750

    Crystalline forms of IRAK degraders

    Expires Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11679109

    SMARCA degraders and uses thereof

    Expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11623932

    Protein degraders and uses thereof

    Expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11591332

    IRAK degraders and uses thereof

    Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11512080

    CRBN ligands and uses thereof

    Expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11485750

    STAT degraders and uses thereof

    Expires Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11485743

    Protein degraders and uses thereof

    Expires Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11352350

    IRAK degraders and uses thereof

    Expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11318205

    IRAK degraders and uses thereof

    Expires Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11117889

    IRAK degraders and uses thereof

    Expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 10874743

    IRAK degraders and uses thereof

    Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Kymera Therapeutics have?

29 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Kymera Therapeutics patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.